US Stock MarketDetailed Quotes

KRON Kronos Bio

Watchlist
  • 0.895
  • -0.037-3.99%
Close Mar 19 16:00 ET
54.57MMarket Cap-0.63P/E (TTM)

Kronos Bio Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
56.62%9.85M
-0.70%2.27M
158.45%2.37M
44.21%2.69M
106.39%2.52M
6.29M
2.29M
917K
1.86M
1.22M
Operating revenue
56.62%9.85M
-0.70%2.27M
158.45%2.37M
44.21%2.69M
106.39%2.52M
--6.29M
--2.29M
--917K
--1.86M
--1.22M
Cost of revenue
Gross profit
Operating expense
-40.66%73.28M
-52.24%13.33M
-47.94%18.09M
-35.30%20.13M
-26.88%21.73M
-9.94%123.49M
-17.12%27.92M
3.59%34.74M
-7.20%31.12M
-18.29%29.71M
Selling and administrative expenses
-36.84%24.62M
-46.55%4.92M
-38.09%5.82M
-38.22%6.37M
-25.36%7.51M
-10.20%38.97M
-12.37%9.21M
-7.27%9.4M
-4.78%10.31M
-15.69%10.06M
-General and administrative expense
-36.84%24.62M
-46.55%4.92M
-38.09%5.82M
-38.22%6.37M
-25.36%7.51M
-10.20%38.97M
-12.37%9.21M
-7.27%9.4M
-4.78%10.31M
-15.69%10.06M
Research and development costs
-42.42%48.66M
-55.04%8.41M
-51.59%12.27M
-33.85%13.77M
-27.65%14.22M
-9.82%84.52M
-19.27%18.7M
8.29%25.34M
-8.35%20.81M
-19.56%19.66M
Operating profit
45.88%-63.43M
56.84%-11.06M
53.54%-15.72M
40.36%-17.45M
32.59%-19.21M
14.52%-117.2M
23.90%-25.63M
-0.86%-33.83M
12.76%-29.25M
21.65%-28.49M
Net non-operating interest income expense
-27.61%6.81M
-40.95%1.34M
-34.39%1.61M
-24.89%1.82M
-9.71%2.04M
140.45%9.4M
19.53%2.27M
91.19%2.45M
287.08%2.43M
2,110.78%2.26M
Non-operating interest income
-27.61%6.81M
-40.95%1.34M
-34.39%1.61M
-24.89%1.82M
-9.71%2.04M
140.45%9.4M
19.53%2.27M
91.19%2.45M
287.08%2.43M
2,110.78%2.26M
Other net income (expense)
-504.08%-29.46M
-720.97%-16.09M
80.18%-578K
-12.79M
-4.88M
-1.96M
-2.92M
Special income (charges)
-504.08%-29.46M
-720.97%-16.09M
--0
80.18%-578K
---12.79M
---4.88M
---1.96M
--0
---2.92M
--0
Income before tax
23.60%-86.08M
-1.95%-25.81M
55.03%-14.11M
45.53%-16.2M
-14.18%-29.96M
15.41%-112.67M
20.33%-25.32M
2.73%-31.37M
9.61%-29.74M
27.65%-26.24M
Income tax
Net income
23.60%-86.08M
-1.95%-25.81M
55.03%-14.11M
45.53%-16.2M
-14.18%-29.96M
15.41%-112.67M
20.33%-25.32M
2.73%-31.37M
9.61%-29.74M
27.65%-26.24M
Net income continuous Operations
23.60%-86.08M
-1.95%-25.81M
55.03%-14.11M
45.53%-16.2M
-14.18%-29.96M
15.41%-112.67M
20.33%-25.32M
2.73%-31.37M
9.61%-29.74M
27.65%-26.24M
Minority interest income
Net income attributable to the parent company
23.60%-86.08M
-1.95%-25.81M
55.03%-14.11M
45.53%-16.2M
-14.18%-29.96M
15.41%-112.67M
20.33%-25.32M
2.73%-31.37M
9.61%-29.74M
27.65%-26.24M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
23.60%-86.08M
-1.95%-25.81M
55.03%-14.11M
45.53%-16.2M
-14.18%-29.96M
15.41%-112.67M
20.33%-25.32M
2.73%-31.37M
9.61%-29.74M
27.65%-26.24M
Basic earnings per share
26.67%-1.43
0.00%-0.43
57.41%-0.23
48.08%-0.27
-8.70%-0.5
17.72%-1.95
23.21%-0.43
5.26%-0.54
11.86%-0.52
29.23%-0.46
Diluted earnings per share
26.67%-1.43
0.00%-0.43
57.41%-0.23
48.08%-0.27
-8.70%-0.5
17.72%-1.95
23.21%-0.43
5.26%-0.54
11.86%-0.52
29.23%-0.46
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 56.62%9.85M-0.70%2.27M158.45%2.37M44.21%2.69M106.39%2.52M6.29M2.29M917K1.86M1.22M
Operating revenue 56.62%9.85M-0.70%2.27M158.45%2.37M44.21%2.69M106.39%2.52M--6.29M--2.29M--917K--1.86M--1.22M
Cost of revenue
Gross profit
Operating expense -40.66%73.28M-52.24%13.33M-47.94%18.09M-35.30%20.13M-26.88%21.73M-9.94%123.49M-17.12%27.92M3.59%34.74M-7.20%31.12M-18.29%29.71M
Selling and administrative expenses -36.84%24.62M-46.55%4.92M-38.09%5.82M-38.22%6.37M-25.36%7.51M-10.20%38.97M-12.37%9.21M-7.27%9.4M-4.78%10.31M-15.69%10.06M
-General and administrative expense -36.84%24.62M-46.55%4.92M-38.09%5.82M-38.22%6.37M-25.36%7.51M-10.20%38.97M-12.37%9.21M-7.27%9.4M-4.78%10.31M-15.69%10.06M
Research and development costs -42.42%48.66M-55.04%8.41M-51.59%12.27M-33.85%13.77M-27.65%14.22M-9.82%84.52M-19.27%18.7M8.29%25.34M-8.35%20.81M-19.56%19.66M
Operating profit 45.88%-63.43M56.84%-11.06M53.54%-15.72M40.36%-17.45M32.59%-19.21M14.52%-117.2M23.90%-25.63M-0.86%-33.83M12.76%-29.25M21.65%-28.49M
Net non-operating interest income expense -27.61%6.81M-40.95%1.34M-34.39%1.61M-24.89%1.82M-9.71%2.04M140.45%9.4M19.53%2.27M91.19%2.45M287.08%2.43M2,110.78%2.26M
Non-operating interest income -27.61%6.81M-40.95%1.34M-34.39%1.61M-24.89%1.82M-9.71%2.04M140.45%9.4M19.53%2.27M91.19%2.45M287.08%2.43M2,110.78%2.26M
Other net income (expense) -504.08%-29.46M-720.97%-16.09M80.18%-578K-12.79M-4.88M-1.96M-2.92M
Special income (charges) -504.08%-29.46M-720.97%-16.09M--080.18%-578K---12.79M---4.88M---1.96M--0---2.92M--0
Income before tax 23.60%-86.08M-1.95%-25.81M55.03%-14.11M45.53%-16.2M-14.18%-29.96M15.41%-112.67M20.33%-25.32M2.73%-31.37M9.61%-29.74M27.65%-26.24M
Income tax
Net income 23.60%-86.08M-1.95%-25.81M55.03%-14.11M45.53%-16.2M-14.18%-29.96M15.41%-112.67M20.33%-25.32M2.73%-31.37M9.61%-29.74M27.65%-26.24M
Net income continuous Operations 23.60%-86.08M-1.95%-25.81M55.03%-14.11M45.53%-16.2M-14.18%-29.96M15.41%-112.67M20.33%-25.32M2.73%-31.37M9.61%-29.74M27.65%-26.24M
Minority interest income
Net income attributable to the parent company 23.60%-86.08M-1.95%-25.81M55.03%-14.11M45.53%-16.2M-14.18%-29.96M15.41%-112.67M20.33%-25.32M2.73%-31.37M9.61%-29.74M27.65%-26.24M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 23.60%-86.08M-1.95%-25.81M55.03%-14.11M45.53%-16.2M-14.18%-29.96M15.41%-112.67M20.33%-25.32M2.73%-31.37M9.61%-29.74M27.65%-26.24M
Basic earnings per share 26.67%-1.430.00%-0.4357.41%-0.2348.08%-0.27-8.70%-0.517.72%-1.9523.21%-0.435.26%-0.5411.86%-0.5229.23%-0.46
Diluted earnings per share 26.67%-1.430.00%-0.4357.41%-0.2348.08%-0.27-8.70%-0.517.72%-1.9523.21%-0.435.26%-0.5411.86%-0.5229.23%-0.46
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion--------

Trending Stocks

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
Hutchmed (China)
HCM
16.180
New Fortress Energy
NFE
10.260
DexCom
DXCM
73.380
4
Dorian LPG
LPG
23.220
5
eBay
EBAY
67.200
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Trump's comeback to the Office
Following Trump's Policies to Seek Investment Opportunities
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
🎙️Discussion1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovati Show More
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings